Nonetheless, accumulated studies indicate that serum MMP-9 may be a novel therapeutic target and biomarker for depression (55–57, 60–63), although a cautionary note is that blood level of MMP-9 may not directly correlate with brain MMP-9 content. The gene discussed is MMP9; the disease is depressive symptom measurement.